Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Hodgkin Disease
×
MK-8776
×
Clear all
Filters
3
NCT00779584
2018-08-27
MK-8776-002
Merck Sharp & Dohme LLC
Phase 1
Completed
45 enrolled
20 charts